Second-Generation Drug-Eluting Stents Moving the Field Forward

被引:65
作者
Alfonso, Fernando [1 ]
Fernandez, Cristina [1 ]
机构
[1] Clin San Carlos Univ Hosp, Intervent Cardiol Cardiovasc Inst, Madrid 28040, Spain
关键词
drug-eluting stents; myocardial infarction; stent thrombosis; CORONARY-ARTERY LESIONS; CLINICAL FOLLOW-UP; SPIRIT II TRIAL; RANDOMIZED-TRIALS; CONSORT STATEMENT; METHODOLOGY; EXTENSION; DISEASE; SYSTEM;
D O I
10.1016/j.jacc.2011.03.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:26 / 29
页数:4
相关论文
共 19 条
[1]   The "Vulnerable" stent - Why so dreadful? [J].
Alfonso, Fernando .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (25) :2403-2406
[2]   Bivalirudin in Acute Myocardial Infarction: "Primum Non Nocere" The Eternal Dilemma: Balancing Risks and Benefits in High-Risk Patients [J].
Alfonso, Fernando ;
Paulo, Manuel .
JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (08) :803-805
[3]   Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial [J].
Claessen, Bimmer E. ;
Beijk, Marcel A. ;
Legrand, Victor ;
Ruzyllo, Witold ;
Manari, Antonio ;
Varenne, Olivier ;
Suttorp, Maarten J. ;
Tijssen, Jan G. P. ;
Miquel-Hebert, Karine ;
Veldhof, Susan ;
Henriques, Jose P. S. ;
Serruys, Patrick W. ;
Piek, Jan J. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) :339-347
[4]   3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions) [J].
Garg, Scot ;
Serruys, Patrick ;
Onuma, Yoshinobu ;
Dorange, Cecile ;
Veldhof, Susan ;
Miquel-Hebert, Karine ;
Sudhir, Krishnankutty ;
Boland, Jean ;
Huber, Kurt ;
Garcia, Eulogio ;
te Riele, Jan A. M. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) :1190-1198
[5]   The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals [J].
Haidich, Anna-Bettina ;
Birtsou, Charis ;
Dardavessis, Theodore ;
Tirodimos, Ilias ;
Arvanitidou, Malamatenia .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (02) :124-135
[6]   Better reporting of harms in randomized trials: An extension of the CONSORT statement [J].
Ioannidis, JPA ;
Evans, SJW ;
Gotzsche, PC ;
O'Neill, RT ;
Altman, DG ;
Schulz, K ;
Moher, D .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (10) :781-788
[7]   Endothelial cell recovery between comparator polymer-based drug-eluting stents [J].
Joner, Michael ;
Nakazawa, Gaku ;
Finn, Aloke V. ;
Quee, Shawn Chin ;
Coleman, Leslie ;
Acampado, Eduardo ;
Wilson, Patricia S. ;
Skorija, Kristi ;
Cheng, Qi ;
Xu, Xin ;
Gold, Herman K. ;
Kolodgie, Frank D. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) :333-342
[8]   Clinical research methodology I: Introduction to randomized trials [J].
Kao, Lillian S. ;
Tyson, Jon E. ;
Blakely, Martin L. ;
Lally, Kevin P. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 206 (02) :361-369
[9]   Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial [J].
Kedhi, Elvin ;
Joesoef, Kaiyum Sheik ;
McFadden, Eugene ;
Wassing, Jochem ;
van Mieghem, Carlos ;
Goedhart, Dick ;
Smits, Pieter Cornelis .
LANCET, 2010, 375 (9710) :201-209
[10]   ISSUES OF DESIGN AND METHODOLOGY IN LONG-TERM FOLLOW-UP STUDIES [J].
MCGLASHAN, TH ;
CARPENTER, WT ;
BARTKO, JJ .
SCHIZOPHRENIA BULLETIN, 1988, 14 (04) :569-574